Viewing Study NCT07013851

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-05-17 @ 3:00 PM
Study NCT ID: NCT07013851
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-10
First Post: 2025-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer
Sponsor: Grupo Español de Investigación en Cáncer de Ovario
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None MMRd/MSI-H Stage II-III Endometrial Cancer View
Keywords: